Editas Medicine Competitors and Similar CompaniesClear all
Editas Medicine's competitors and similar companies include Biocytogen Boston and Amyris.
 Editas Medicine Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics. |  Amyris Amyris is a biotechnology company that develops chemical ingredients using microbial fermentation. | ||
Founding Date | Founding Date 2013 | Founding Date 2008 | Founding Date 2003 |
Type | Type Public | Type Subsidiary | Type Private |
Tags | |||
Locations | Locations Cambridge, US HQ Boulder, US Cambridge, US | Locations Waltham, US HQ Beijing, CN Nantong, CN Shanghai, CN Heidelberg, DE San Diego, US San Francisco, US | Locations Emeryville, US HQ Sao Paulo, BR |
Employees | Employees 20816% increase | Employees 1833% increase | Employees 1,0031% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) $40.5m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $269.8m (FY, 2022) |
Net income | Net income ($160.1m) (FY, 2025) | Net income N/A | Net income ($543.4m) (FY, 2022) |
Funding | |||
Total funding raised | Total funding raised $ 210m | Total funding raised $ 284.3m | Total funding raised $ 551.9m |
For sources of this data, please see the company profile
View Company Profiles
Biocytogen Boston
HQ
Waltham, US
Biocytogen Boston is a company that provides antibody drug development solutions.
View companyAmyris
HQ
Emeryville, US
Employees
1,003↓ 1% decrease
Amyris is a biotechnology company that develops chemical ingredients using microbial fermentation.
View company